Vilaprisan for the treatment of symptomatic endometriosis: results from a terminated phase 2b randomized controlled trial
Objective: To evaluate the efficacy and safety of 2 doses of vilaprisan vs. placebo in participants with symptomatic endometriosis. Design: Multicenter, randomized, double-blind, placebo-controlled, parallel-group phase 2b trial (NCT03573336). The initially planned sample size was 315 patients. Recr...
Spremljeno u:
| Glavni autori: | , , , , , , , , , |
|---|---|
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Elsevier
2024-06-01
|
| Serija: | F&S Reports |
| Teme: | |
| Online pristup: | http://www.sciencedirect.com/science/article/pii/S2666334124000436 |
| Oznake: |
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|